“EARLY DETECTION OF BIPOLAR DISORDERS AND TREATMENT RECOMMENDATIONS FOR HELP-SEEKING ADOLESCENTS AND YOUNG ADULTS: FINDINGS OF THE EARLY DETECTION AND INTERVENTION CENTER”
Main Article Content
Keywords
Bipolar disorder, early detection, adolescents, treatment recommendations, mental health, comorbidity
Abstract
Background: Bipolar disorder (BD) is a debilitating mental health condition, often undiagnosed for years, which significantly impacts individuals and society. Early detection is crucial for improving treatment outcomes and reducing disability.
Methods: This cross-sectional study involved 300 adolescents and young adults at a private hospital. Participants were assessed using standardized diagnostic procedures and early recognition instruments. Data collected included sociodemographic information, psychiatric history, substance use, and treatment history, analyzed through SPSS version 26.
Results: Among the participants, 70 were identified as at risk for or manifesting BD, while 230 were not. Significant differences were found in substance use, with higher rates of nicotine (40% vs. 26.96%), alcohol (30% vs. 20%), and cannabis (48.57% vs. 33.91%) in the at-risk group. Furthermore, 71.43% of the at-risk group were diagnosed with mood disorders compared to 38.26% in the not-at-risk group. A notable 17.14% of the at-risk group had a diagnosis of manic episodes/Bipolar affective disorder, absent in the not-at-risk group. Individuals at risk showed a greater prevalence of comorbidity and a higher history of psychiatric treatment.
Conclusion: The findings emphasize the importance of early detection and intervention for BD in adolescents and young adults. Identifying at-risk individuals and addressing their unique needs can enhance treatment efficacy and improve long-term outcomes. This study underscores the need for structured early detection programs within healthcare systems.
References
2. Martini J, Leopold K, Pfeiffer S, Berndt C, Boehme A, Roessner V, Fusar-Poli P, Young AH, Correll CU, Bauer M, Pfennig A. Early detection of bipolar disorders and treatment recommendations for help-seeking adolescents and young adults: Findings of the Early Detection and Intervention Center Dresden. Int J Bipolar Disord. 2021 Jul 2;9(1):23. doi: 10.1186/s40345-021-00227-3. PMID: 34215910; PMCID: PMC8253866.
3. Bauer M, Pfennig A. Epidemiology of bipolar disorders. Epilepsia. 2005;46 Suppl 4:8-13. doi: 10.1111/j.1528-1167.2005.463003.x. PMID: 15968806.
4. da Silva Lima AF, Cruz L, Cohen M, Zimmermann JJ, de Sousa Miguel SR. Cost-effectiveness of treatment for bipolar disorders. Mental health economics: The costs and benefits of psychiatric care. 2017:299-311.
5. Dagani J, Signorini G, Nielssen O, Bani M, Pastore A, Girolamo GD, Large M. Meta-analysis of the interval between the onset and management of bipolar disorder. The Canadian Journal of Psychiatry. 2017 Apr;62(4):247-58.
6. Pfennig A, Correll CU, Leopold K, Juckel G, Bauer M. Early recognition and intervention for bipolar disorders: state of research and perspectives. Der Nervenarzt. 2012 Jul;83:897-902.
7. Martini J, Bröckel KL, Leopold K, Berndt C, Sauer C, Maicher B, Juckel G, Krüger-Özgürdal S, Fallgatter AJ, Lambert M, Bechdolf A. Young people at risk for developing bipolar disorder: Two-year findings from the multicenter prospective, naturalistic Early-BipoLife study. European Neuropsychopharmacology. 2024 Jan 1;78:43-53.
8. Leopold K, Ratzer S, Correll CU, Rottmann-Wolf M, Pfeiffer S, Ritter P, Bauer M, Pfennig A. Characteristics, symptomatology and naturalistic treatment in individuals at-risk for bipolar disorders: baseline results in the first 180 help-seeking individuals assessed at the Dresden high-risk project. Journal of affective disorders. 2014 Jan 1;152:427-33.
9. Collins C, Copeland B, Croucher M. Bipolar affective disorder, type II, apparently precipitated by donepezil. International psychogeriatrics. 2011 Apr;23(3):503-4.
10. Forsman AK, Ventus DB, van der Feltz-Cornelis CM, Wahlbeck K. Public mental health research in Europe: a systematic mapping for the ROAMER project. The European Journal of Public Health. 2014 Dec 1;24(6):955-60.
11. Faedda GL, Baldessarini RJ, Marangoni C, Bechdolf A, Berk M, Birmaher B, Conus P, DelBello MP, Duffy AC, Hillegers MH, Pfennig A. An International Society of Bipolar Disorders task force report: Precursors and prodromes of bipolar disorder. Bipolar disorders. 2019 Dec;21(8):720-40.
12. Van Meter AR, Burke C, Youngstrom EA, Faedda GL, Correll CU. The bipolar prodrome: meta-analysis of symptom prevalence prior to initial or recurrent mood episodes. Journal of the American Academy of Child & Adolescent Psychiatry. 2016 Jul 1;55(7):543-55.
13. Scott J, Marwaha S, Ratheesh A, Macmillan I, Yung AR, Morriss R, Hickie IB, Bechdolf A. Bipolar at-risk criteria: an examination of which clinical features have optimal utility for identifying youth at risk of early transition from depression to bipolar disorders. Schizophrenia bulletin. 2017 Jul 1;43(4):737-44.
14. Vieta E, Salagre E, Grande I, Carvalho AF, Fernandes BS, Berk M, Birmaher B, Tohen M, Suppes T. Early intervention in bipolar disorder. American Journal of Psychiatry. 2018 May 1;175(5):411-26.
15. Pfennig A, Ritter PS, Höfler M, Lieb R, Bauer M, Wittchen HU, Beesdo‐Baum K. Symptom characteristics of depressive episodes prior to the onset of mania or hypomania. Acta Psychiatrica Scandinavica. 2016 Mar;133(3):196-204.
16. Leopold K, Ritter P, Correll CU, Marx C, Özgürdal S, Juckel G, Bauer M, Pfennig A. Risk constellations prior to the development of bipolar disorders: rationale of a new risk assessment tool. Journal of affective disorders. 2012 Feb 1;136(3):1000-10.
17. Bechdolf A, Ratheesh A, J Wood S, Tecic T, Conus P, Nelson B, M Cotton S, M Chanen A, P Amminger G, Ruhrmann S, Schultze-Lutter F. Rationale and first results of developing at-risk (prodromal) criteria for bipolar disorder. Current pharmaceutical design. 2012 Feb 1;18(4):358-75.
18. Fusar-Poli P, De Micheli A, Rocchetti M, Cappucciati M, Ramella-Cravaro V, Rutigliano G, Bonoldi I, McGuire P, Falkenberg I. Semistructured interview for bipolar at risk states (SIBARS). Psychiatry research. 2018 Jun 1;264:302-9.
19. Brietzke E, Mansur RB, Soczynska JK, Kapczinski F, Bressan RA, McIntyre RS. Towards a multifactorial approach for prediction of bipolar disorder in at risk populations. Journal of affective disorders. 2012 Sep 1;140(1):82-91.
20. Goldstein BI, Strober M, Axelson D, Goldstein TR, Gill MK, Hower H, Dickstein D, Hunt J, Yen S, Kim E, Ha W. Predictors of first-onset substance use disorders during the prospective course of bipolar spectrum disorders in adolescents. Journal of the American Academy of Child & Adolescent Psychiatry. 2013 Oct 1;52(10):1026-37.
21. Leopold K, Ritter P, Correll CU, Marx C, Özgürdal S, Juckel G, Bauer M, Pfennig A. Risk constellations prior to the development of bipolar disorders: rationale of a new risk assessment tool. Journal of affective disorders. 2012 Feb 1;136(3):1000-10.
22. Van Meter AR, Burke C, Youngstrom EA, Faedda GL, Correll CU. The bipolar prodrome: meta-analysis of symptom prevalence prior to initial or recurrent mood episodes. Journal of the American Academy of Child & Adolescent Psychiatry. 2016 Jul 1;55(7):543-55.
23. Beesdo-Baum K, Knappe S, Asselmann E, Zimmermann P, Brückl T, Höfler M, Behrendt S, Lieb R, Wittchen HU. The ‘Early Developmental Stages of Psychopathology (EDSP) study’: a 20-year review of methods and findings. Social Psychiatry and Psychiatric Epidemiology. 2015 Jun;50:851-66.
24. Mack S, Jacobi F, Gerschler A, Strehle J, Höfler M, Busch MA, Maske UE, Hapke U, Seiffert I, Gaebel W, Zielasek J. Self‐reported utilization of mental health services in the adult German population–evidence for unmet needs? Results of the DEGS1‐Mental Health Module (DEGS1‐MH). International journal of methods in psychiatric research. 2014 Sep;23(3):289-303.
25. Krishnan KR. Psychiatric and medical comorbidities of bipolar disorder. Psychosomatic medicine. 2005 Jan 1;67(1):1-8.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Dr. Mulchand Harjani
Assistant Professor At Department Of Psychiatry, Shri Balaji Institute Of Medical Sciences, Raipur, Chhattisgarh, India
Dr. Sonia Parial
Director At Department of Psychiatry, Dhanwantari Hospital, Raipur, Chhattisgarh, India
Dr. P N Shukla
Director At Department of Psychiatry, Manopchar Hospital, Raipur, Chhattisgarh, India